The clinical result of the Micro Pulse Infusion Pump has been published in the (2011-8). The clinical results, also proved the efficacy of the new product. Developed jointly by Shanghai MicroPortLifesciences Co., Ltd. and Shanghai Ruijin Hospital, the pulsatile infusion of Gonadotropin-Releasing Hormone (GnRH) is for the treatment of idiopathic hypogonadotropichypogonadism (IHH). In China, research and study into pulse therapy began during the 1980’s, and for China this is the first micro pulse infusion system which can be used for the effective treatment of IHH. It’s a small-sized device with microcomputer-control micro-precision motor for accurate and safehypodermatoclysis. It is also featured as personalized settings, simple operation and easy to carry.